Antibiotic Resistance: Finding the right sequence of drugs

Rapidly switching between similar antibiotics may help to slow down the evolution of resistance.
  1. Anh Huynh
  2. Kevin B Wood  Is a corresponding author
  1. Department of Biophysics, University of Michigan, United States
  2. Department of Physics, University of Michigan, United States

In order to survive, many living organisms need to be able to adapt to their ever-changing environment. These past experiences shape the behavior of creatures big and small – from mutations in single genes to neurological changes that underlie memory formation in primates.

There is substantial evidence that environmental history affects how bacteria respond to antibiotics (Barbosa et al., 2019; Card et al., 2019; Nichol et al., 2019; Santos-Lopez et al., 2019; Yen and Papin, 2017). This has led researchers to suggest that switching between drugs over time could help slow down antibiotic resistance, as this will force the bacteria into a scenario where their existing solutions (resistance to the current drug) cannot protect them from tomorrow’s problem (a new drug). However, this method has led to mixed results (Abel zur Wiesch et al., 2014; Imamovic et al., 2018), and optimizing this approach is challenging, in part because it is unclear which features of the antibiotic sequence are the most important and guarantee the best results.

Now, in eLife, Hinrich Schulenburg (University of Kiel and Max Planck Institute for Evolutionary Biology) and colleagues – including Aditi Batra and Roderich Roemhild as joint first authors – report the results of experiments on the multi-drug resistant bacteria Pseudomonas aeruginosa (Batra et al., 2021). The team (who are based in Austria and Germany) exposed the bacteria to various sequences of three antibiotics that belong to commonly used classes of drugs: one class targets the ribosome, one targets DNA gyrase, and one targets the cell wall. In some cases, three drugs from different classes were used (that is, a heterogeneous sequence), and in some cases all three drugs belonged to the same class (a homogenous sequence). Batra et al. also varied the temporal properties of each sequence by switching between the drugs rapidly, slowly, or in a random order. The growth rate, phenotypic resistance levels and population genetics of the evolved populations were then analyzed to determine which sequences of drugs were the most effective at eliminating the bacteria (Figure 1A).

Experimental and biological features of effective drug sequences.

(A) Batra et al. applied different sequences of antibiotics to 756 populations of P. aeruginosa (top panel). The bacteria were treated with either a single drug (monotherapy; row 1), or three antibiotics which were switched rapidly (row 2), slowly (row 3) or in a random order (row 4): the three drugs were either from the same class (homogeneous) or from different classes (heterogeneous). This experiment revealed that fast (blue line) and random (green line) switching between three homogeneous beta-lactam drugs reduced bacteria growth and resulted in higher levels of extinction (bottom graph). (B) The effects of the different sequences are also impacted by biological features. (Top panel) When sensitive bacteria (shown in purple) are treated with the first drug, some cells will evolve genetic changes that make them resistant to the antibiotic treatment (shown in green). These evolutionary changes can lead to collateral effects that make the bacteria less (top arrow), equally (middle arrow) or more (bottom arrow) resistant to the second drug. (Bottom panel) Treatment with the first drug may also lead to negative hysteresis, when short-term physiological changes enhance the bacteria’s response to the second drug (right), leading to more cell death in the population compared to bacteria not pre-treated with the first drug (left).

Image credit: Anh Huynh.

In addition to these experimental parameters, the impact of different antibiotic sequences could also depend on how the population biologically responds to consecutive drug exposures (Figure 1B). For example, the genetic changes bacteria evolve in response to one antibiotic can lead to collateral effects that increase the population’s resistance or sensitivity to another drug. Because collateral resistance occurs more frequently between drugs of the same class, heterogeneous sequences of antibiotics are thought to be more effective at eliminating bacteria (Imamovic and Sommer, 2013; Lázár et al., 2013; Maltas and Wood, 2019; Pál et al., 2015; Lázár et al., 2014). Treatment with unrelated drugs has also been shown to favor negative hysteresis, which is when short-term physiological changes induced by one antibiotic enhance susceptibility towards another. Indeed, a recent study found that rapid switching between antibiotics from different classes promoted extinction of bacterial populations, even when the drugs were used at sub-inhibitory levels (Roemhild et al., 2018).

However, Batra et al. found that homogenous sequences of beta-lactams (a class of antibiotics that target the cell wall) were surprisingly more effective at clearing bacteria. The experiments also revealed that extinction tended to occur early in the treatment and was less effective when drugs were switched more slowly. A particular heterogeneous set of drugs also tended to not eliminate bacteria, indicating that heterogeneity, alone, does not guarantee success.

So, what are the important characteristics of a ‘good’ antibiotic sequence? To answer this question, Batra et al. used a common class of statistical models to probe for signatures of successful sequences. They found that extinction was strongly favored by two biological properties — low rates of spontaneous resistance and low levels of collateral resistance — and was also enhanced when switching between drugs was fast or random. This suggests that although thefindings of Batra et al. contradict the proposed benefits of using unrelated drugs, they still validate a portion of the underlying logic: using antibiotics with strong collateral effects and hysteresis enhances the impact of sequence therapy. It just turns out, however, that drugs with these characteristics are not always from different classes.

This study offers insight into how past antibiotic exposure shapes the response of bacterial populations to new challenges. In doing so, it provides a roadmap for future studies investigating how even the simplest organisms harbor signatures of past challenges and potential evolutionary solutions.

References

Article and author information

Author details

  1. Anh Huynh

    Anh Huynh is in the Department of Biophysics, University of Michigan, Ann Arbor, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8891-4234
  2. Kevin B Wood

    Kevin B Wood is in the Department of Biophysics and Department of Physics, University of Michigan, Ann Arbor, United States

    For correspondence
    kbwood@umich.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0985-7401

Publication history

  1. Version of Record published:

Copyright

© 2021, Huynh and Wood

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,238
    views
  • 90
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anh Huynh
  2. Kevin B Wood
(2021)
Antibiotic Resistance: Finding the right sequence of drugs
eLife 10:e72562.
https://doi.org/10.7554/eLife.72562
  1. Further reading

Further reading

    1. Ecology
    2. Evolutionary Biology
    Vendula Bohlen Šlechtová, Tomáš Dvořák ... Joerg Bohlen
    Research Article

    Eurasia has undergone substantial tectonic, geological, and climatic changes throughout the Cenozoic, primarily associated with tectonic plate collisions and a global cooling trend. The evolution of present-day biodiversity unfolded in this dynamic environment, characterised by intricate interactions of abiotic factors. However, comprehensive, large-scale reconstructions illustrating the extent of these influences are lacking. We reconstructed the evolutionary history of the freshwater fish family Nemacheilidae across Eurasia and spanning most of the Cenozoic on the base of 471 specimens representing 279 species and 37 genera plus outgroup samples. Molecular phylogeny using six genes uncovered six major clades within the family, along with numerous unresolved taxonomic issues. Dating of cladogenetic events and ancestral range estimation traced the origin of Nemacheilidae to Indochina around 48 mya. Subsequently, one branch of Nemacheilidae colonised eastern, central, and northern Asia, as well as Europe, while another branch expanded into the Burmese region, the Indian subcontinent, the Near East, and northeast Africa. These expansions were facilitated by tectonic connections, favourable climatic conditions, and orogenic processes. Conversely, aridification emerged as the primary cause of extinction events. Our study marks the first comprehensive reconstruction of the evolution of Eurasian freshwater biodiversity on a continental scale and across deep geological time.

    1. Evolutionary Biology
    Ljiljana Mihajlovic, Bharat Ravi Iyengar ... Yolanda Schaerli
    Research Article

    Gene duplication drives evolution by providing raw material for proteins with novel functions. An influential hypothesis by Ohno (1970) posits that gene duplication helps genes tolerate new mutations and thus facilitates the evolution of new phenotypes. Competing hypotheses argue that deleterious mutations will usually inactivate gene duplicates too rapidly for Ohno’s hypothesis to work. We experimentally tested Ohno’s hypothesis by evolving one or exactly two copies of a gene encoding a fluorescent protein in Escherichia coli through several rounds of mutation and selection. We analyzed the genotypic and phenotypic evolutionary dynamics of the evolving populations through high-throughput DNA sequencing, biochemical assays, and engineering of selected variants. In support of Ohno’s hypothesis, populations carrying two gene copies displayed higher mutational robustness than those carrying a single gene copy. Consequently, the double-copy populations experienced relaxed purifying selection, evolved higher phenotypic and genetic diversity, carried more mutations and accumulated combinations of key beneficial mutations earlier. However, their phenotypic evolution was not accelerated, possibly because one gene copy rapidly became inactivated by deleterious mutations. Our work provides an experimental platform to test models of evolution by gene duplication, and it supports alternatives to Ohno’s hypothesis that point to the importance of gene dosage.